Docosahexaenoic Acid Market Share

APAC Market Forecast

Docosahexaenoic acid market in Asia Pacific, is predicted to account for the largest share of about 42% by 2036 impelled by growing healthcare expenditure. Rising healthcare spending in healthcare may increase awareness among individuals and medical professionals about the importance of DHA in maintaining overall health.

As a result, people in the region are likely to seek out products such as DHA-enriched infant formulas, baby food, and other supplements.

North American Market Statistics

The North American docosahexaenoic acid (DHA) market is estimated to be the second largest, during the forecast timeframe led by the surging numbers of consumers who have been opting for concentrated dietary supplements to address their nutritional needs for DHA. For instance, the region's population is becoming more concerned with their own health, which has led to an increase in demand for concentrated dietary supplements to meet their nutritional needs for DHA and promote their well-being.

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of docosahexaenoic acid is estimated at USD 4.42 Billion.

The docosahexaenoic acid market size was over USD 4.1 Billion in 2023 and is poised to cross USD 13.62 Billion by the end of 2036, witnessing more than 10% CAGR during the forecast period i.e., between 2024-2036. Escalating cases of depression and surging risk of preterm births across the globe are the major factors driving the growth of the market.

Asia Pacific industry is predicted to account for the largest share of about 42% by 2036, impelled by growing healthcare expenditure in the region.

Koninklijke DSM N.V., BASF SE, Croda International Plc, Cellana, Inc., Far East Microalgae Industries, Co., Ltd.(FEMICO), Pelagia AS, Corbion NV, JC Biotech Private Limited, Source Omega LLC, Shandong Yuexiang Biotechnology Co., Ltd.

Docosahexaenoic Acid Market Share